Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 4:47 PM
Ignite Modification Date: 2025-12-24 @ 4:47 PM
NCT ID: NCT02657850
Eligibility Criteria: Inclusion Criteria - Head and Neck Cancer Study Subjects: 1. Previously untreated head and neck cancer of any histology receiving treatment with curative oncologic intent regardless of the treatment modality. 2. Capable of providing informed consent. Inclusion Criteria - Non-Head and Neck Cancer Study Subjects 1. Previously untreated cancer of any histology with no prior history of swallowing disorder and receiving radiation or concurrent chemoradiation or chemotherapy followed by radiation or concurrent chemoradiation. 2. Screening SSQ \<234 prior to any cancer treatment. 3. Capable of providing informed consent. Exclusion Criteria - 1. Potential study subjects who are unwilling or unable to be adherent to longitudinal assessment and follow-up. This will include potential study subjects who have poor performance status at the time of study enrollment evaluation. 2. Potential study subjects who have cognitive limitations / impairments that prevent a potential study subject's ability to provide self-reporting with the SSQ instrument and/or other data elements required as described in the study calendar. 3. Potential study subjects who have motor skill limitations that prevent a potential study subject's ability to provide self-reporting with the SSQ instrument and/or other data elements required as described in the study calendar.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 100 Years
Study: NCT02657850
Study Brief:
Protocol Section: NCT02657850